ArticleJournal of neuro-oncology2022

EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.

Hung-Ruei Liao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.